fusiform antibiotics | fusidic acid is also known as fusiform acid, Brown mold sodium, furomycin, or stiromycin, is a fusicyclosporine antibiotic with a steroid skeleton, and its chemical structure is similar to that of cephalosporin P, not a hormone, it is produced by Fusobacterium coccineum or some Cephalosporium spp in fungi. The antibacterial spectrum is narrow, similar to novobiocin, but has a significant effect on Bacteroides fragilis and a weaker effect on streptococci spp, Pneumonia streptococci. Its mechanism of action is to inhibit bacterial protein synthesis, antibacterial or bactericidal effect. It has strong antibacterial effect on Staphylococcus (including methicillin resistant strains or other antibiotic resistant strains), Streptococcus, Enterococcus, diphtheria, Clostridium, neisseria and Mycobacterium tuberculosis also have certain antibacterial effect, weak effect on Bacteroides fragilis. Gram-negative bacteria in addition to Neisseria gonorrhoeae, Neisseria meningitidis, Clostridium difficile, fragile Bacteroides and other sensitive to this product, the other are resistant to this product. In vitro, Staphylococcus is very easy to produce resistance to this product. There was no cross-resistance between this drug and other anti-infective drugs. fusidic acid is clinically used for osteomyelitis or skin and soft tissue infections caused by sensitive bacteria. It is also used for other antibiotics treatment failure of deep infection, such as sepsis, Pneumonia, endocarditis, etc. Adults: oral, once 500mg,tid; Severe double. Local administration, bid ~ tid, applied to the affected area, treatment for 7 days. Treatment of scabies can be based on the need to extend the course of treatment. Children: oral, for children under 1 year old, 50mg/kg daily, three times; For children aged 1 to 5 years old, 250mg once, tid; For children aged 5 to 12 years old, usage and dosage with adult. |
pharmacokinetics | sodium fusidate has excellent tissue permeability and is widely distributed in the body. It is particularly important clinically that the product not only has a high concentration in tissues with abundant blood supply, but also has a high concentration even in tissues with less vascular distribution. Known in pus, sputum, soft tissue, heart, bone tissue, synovial fluid, dead bone pieces, burn scabs, brain abscesses, and intraocular, the concentration of sodium fusidate exceeded its minimum inhibitory concentration against Staphylococcus (0.03~0.16 μg/ml). Sodium fusidate is metabolized in the liver and excreted mainly by bile and almost not by the kidneys. This product is very low toxicity, and clinical use of other antimicrobial drugs without cross-allergy, so it can be used for the treatment of patients with other antibiotic contraindications, such as allergic to penicillin or other antibiotics. Sodium fusidate is recommended to be used in combination with other anti-staphylococcal agents to reduce the development of resistance when prolonged use is required due to severe or deep infection. Sodium fusidate can be used in combination with penicillinase-resistant penicillins, cephalosporins, erythromycin, aminoglycosides, lincomycin, rifampicin or vancomycin, and additive or synergistic effects can be obtained. |
Use | in clinical application, sodium salt is usually prepared, and the molecular formula of sodium salt is C31H47NaO6. Fusidic acid is highly sensitive to various Gram-positive cocci associated with skin infections, especially to staphylococci, is also effective against resistant Staphylococcus aureus, and also has some antibacterial effect against some Gram-negative bacteria. No cross-resistance to other antibiotics |